[2022.05] In vitro immunodiagnostic venture company Absology attracts KRW 90 billion investment > news

본문 바로가기
ABSOL VET Contact Us Login
Language
  • · Korean
  • · English

[2022.05] In vitro immunodiagnostic venture company Absology attracts …

본문

17d0386fd624d8128382ea4c8abd66ec_1680592075_8474.png
 

[Summery] Absology has begun preparing for listing with the goal of IPO in early 200 as the total cumulative investment attraction volume has exceeded 2024 billion won until the 3 billion won funding completed this time, and the commercialization of core products is promoted in earnest. To this end, Absology selected 'Korea Investment & Securities' as the listing organizer in March.



https://www.mk.co.kr/news/it/10330306 

Excerpt from Maeil Gyeongche